1. Home
  2. RBCAA vs NVAX Comparison

RBCAA vs NVAX Comparison

Compare RBCAA & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RBCAA
  • NVAX
  • Stock Information
  • Founded
  • RBCAA 1974
  • NVAX 1987
  • Country
  • RBCAA United States
  • NVAX United States
  • Employees
  • RBCAA N/A
  • NVAX N/A
  • Industry
  • RBCAA Major Banks
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • RBCAA Finance
  • NVAX Health Care
  • Exchange
  • RBCAA Nasdaq
  • NVAX Nasdaq
  • Market Cap
  • RBCAA 1.3B
  • NVAX 1.3B
  • IPO Year
  • RBCAA 1998
  • NVAX 1995
  • Fundamental
  • Price
  • RBCAA $63.82
  • NVAX $6.41
  • Analyst Decision
  • RBCAA
  • NVAX Buy
  • Analyst Count
  • RBCAA 0
  • NVAX 6
  • Target Price
  • RBCAA N/A
  • NVAX $17.83
  • AVG Volume (30 Days)
  • RBCAA 24.7K
  • NVAX 3.4M
  • Earning Date
  • RBCAA 04-24-2025
  • NVAX 05-09-2025
  • Dividend Yield
  • RBCAA 2.81%
  • NVAX N/A
  • EPS Growth
  • RBCAA 12.83
  • NVAX N/A
  • EPS
  • RBCAA 5.14
  • NVAX N/A
  • Revenue
  • RBCAA $330,428,000.00
  • NVAX $682,162,000.00
  • Revenue This Year
  • RBCAA $1.56
  • NVAX N/A
  • Revenue Next Year
  • RBCAA $3.87
  • NVAX $15.02
  • P/E Ratio
  • RBCAA $12.55
  • NVAX N/A
  • Revenue Growth
  • RBCAA 6.29
  • NVAX N/A
  • 52 Week Low
  • RBCAA $46.81
  • NVAX $3.81
  • 52 Week High
  • RBCAA $80.68
  • NVAX $23.86
  • Technical
  • Relative Strength Index (RSI)
  • RBCAA 43.37
  • NVAX 29.64
  • Support Level
  • RBCAA $64.26
  • NVAX $7.47
  • Resistance Level
  • RBCAA $66.15
  • NVAX $7.81
  • Average True Range (ATR)
  • RBCAA 1.39
  • NVAX 0.34
  • MACD
  • RBCAA 0.03
  • NVAX -0.12
  • Stochastic Oscillator
  • RBCAA 20.56
  • NVAX 5.80

About RBCAA Republic Bancorp Inc.

Republic Bancorp Inc operates as a financial institution that provides both traditional and non-traditional banking products through six reportable segments. It has traditional banking which generates the majority of revenue, warehouse, mortgage banking, Tax Refund Solutions (TRS), Republic Payment Solutions segment, and Republic Credit Solutions (RCS) business segments. The business activities of these segments include retail mortgage and commercial lending, construction and land development lending, internet lending, correspondent and indirect lending and also private banking, treasury management services, internet, and mobile banking, bank acquisitions, short-term revolving credit facilities, fixed-term residential real estate loans and receipt and payment of federal.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

Share on Social Networks: